Talasing, Salvador C.
HRN: 09-48-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
AZITHROMYCIN 500MG TABLET (TAB)
10/23/2023
10/27/2023
PO
500mg
Q24h
Presumptive TB, COPD, CAP-LR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes